Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, has appointed Francis Cano to its board of directors effective November 3, 2009.

http://www.infogrok.com/index.php/pharamaceutical/dynavax-ap...
Print the post Back To Top
No. of Recommendations: 0
DVAX to present clinical data this weekend at 57th American Society of Hematology in Orlando
Print the post Back To Top